EIF2A and melanoma: Activity of the protein kinase PERK was indirectly quantified using phosphorylated eIF2α (Eukaryotic translation initiation factor 2 subunit alpha) and showed a strong increase after the CAP treatment of the melanoma cell line Mel Juso (Figure 1A).